BioStem Technologies, Inc. (BSEM) Tops Q3 EPS by 6c

BioStem Technologies, Inc. (OTC: BSEM) reported Q3 EPS of $0.42, $0.06 better than the analyst estimate of $0.36. Revenue for the quarter came in at $82.56 million versus the consensus estimate of $78.22 million.

For earnings history and earnings-related data on BioStem Technologies, Inc. (BSEM) click here.

You May Also Be Interested In

• Apple announced foldable iPhone Duo, starting at $1,999
• Apple introduces 'Apple Reference Image' standard to prove authenticity of photos at time of capture
• Oppenheimer Reiterates Outperform Rating on Compass Pathways (CMPS)